Page last updated: 2024-10-31

nafamostat and Pruritus

nafamostat has been researched along with Pruritus in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Pruritus: An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.

Research Excerpts

ExcerptRelevanceReference
" The dose-response curve of tryptase action was bell-shaped and the effect peaked at 0."1.33Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. ( Andoh, T; Kuraishi, Y; Lee, JB; Nojima, H; Ui, H, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhand, A1
Aminoff, MJ1
Ui, H1
Andoh, T1
Lee, JB1
Nojima, H1
Kuraishi, Y1

Reviews

1 review available for nafamostat and Pruritus

ArticleYear
The neurology of itch.
    Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamidines; Guanidines; Histamine; Histamine Ant

2014

Other Studies

1 other study available for nafamostat and Pruritus

ArticleYear
Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: Animals; Antibodies; Antipruritics; Benzamidines; Dose-Response Relationship, Drug; Extravasation of

2006